Note 7 - Stockholders' Deficit	9 Months Ended
Sep. 30, 2019
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note 7 – Stockholders’ Deficit Shares for Stock Based Compensation During the nine months ending September 30, 2019, the Company issued 200,000 restricted shares of the Company’s common stock at valued $17,480 in exchange for services conducted on behalf of the Company. The value of these shares was based on the closing market price on the respective date of grant. Also, during the nine months ended September 30, 2019, the Company issued 2,975,000 shares of common stock to employees, subject to vesting provisions, pursuant to employment agreements. The par value of these shares in the amount of $29,750 was credited to paid-in capital. During the nine months ended September 30, 2019, the Company charged the amount of $154,558 to paid-in capital representing the vesting of shares issued to employees. During the nine months ending September 30, 2018, the Company issued 4,100,000 restricted shares of the Company’s common stock at valued $345,430 in exchange for services provided. The value of these shares was based on the closing market price on the respective date of grant. Stock-based compensation expenses are included in general and administrative expenses on the condensed consolidated statements of operations. Shares issued for notes payable During the nine months ended September 30, 2019, the Company issued, in 24 transactions, a total of 14,394,002 shares in connection with the conversion of notes payable principal, accrued interest, and fees in the aggregate amounts of $368,882 and $26,330, and $1,500, respectively; a loss in the aggregate amount of $161,458 was recognized on these transactions (see note 5). During the nine months ending September 30, 2018, the Company issued 150,000 restricted shares of common stock valued at $13,850 for an extension of the term of a note payable. Shares issued for conversion of accounts payable During the nine months ended September 30, 2019, the Company did not issue any shares to settle accounts payable. During the nine months ending September 30, 2018, the Company issued 5,817,122 shares valued at $534,767 to settle outstanding accounts payable. There was a loss on the transaction of $32,860 because the fair value of the issuance exceeded the fair value of the accounts payable settled. Stock returned for cancellation During the nine months ended September 30, 2019, the Company cancelled an aggregate 700,000 shares of common stock issued to former executive officers. During the nine months ended September 30, 2018. there were no cancellations of common stock. Shares issued for legal settlement During the nine months ended September 30, 2019, the Company issued 1,401,224 shares of common stock in connection with the settlement of a note payable in the amount of $74,104. The Company recorded a loss in the amount of $26,924 in connection with this transaction. During the nine months ended September 30, 2018. there were no shares issued in connection with a legal settlement.

Note 7 – Stockholders’ Deficit

Shares for Stock Based Compensation

During the nine months ending September 30, 2019, the Company issued 200,000 restricted shares of the Company’s common stock at valued $17,480 in exchange for services conducted on behalf of the Company. The value of these shares was based on the closing market price on the respective date of grant. Also, during the nine months ended September 30, 2019, the Company issued 2,975,000 shares of common stock to employees, subject to vesting provisions, pursuant to employment agreements. The par value of these shares in the amount of $29,750 was credited to paid-in capital. During the nine months ended September 30, 2019, the Company charged the amount of $154,558 to paid-in capital representing the vesting of shares issued to employees.

During the nine months ending September 30, 2018, the Company issued 4,100,000 restricted shares of the Company’s common stock at valued $345,430 in exchange for services provided. The value of these shares was based on the closing market price on the respective date of grant.

Stock-based compensation expenses are included in general and administrative expenses on the condensed consolidated statements of operations.

Shares issued for notes payable

During the nine months ended September 30, 2019, the Company issued, in 24 transactions, a total of 14,394,002 shares in connection with the conversion of notes payable principal, accrued interest, and fees in the aggregate amounts of $368,882 and $26,330, and $1,500, respectively; a loss in the aggregate amount of $161,458 was recognized on these transactions (see note 5).

During the nine months ending September 30, 2018, the Company issued 150,000 restricted shares of common stock valued at $13,850 for an extension of the term of a note payable.

Shares issued for conversion of accounts payable

During the nine months ended September 30, 2019, the Company did not issue any shares to settle accounts payable.

During the nine months ending September 30, 2018, the Company issued 5,817,122 shares valued at $534,767 to settle outstanding accounts payable. There was a loss on the transaction of $32,860 because the fair value of the issuance exceeded the fair value of the accounts payable settled.

Stock returned for cancellation

During the nine months ended September 30, 2019, the Company cancelled an aggregate 700,000 shares of common stock issued to former executive officers.

During the nine months ended September 30, 2018. there were no cancellations of common stock.

Shares issued for legal settlement

During the nine months ended September 30, 2019, the Company issued 1,401,224 shares of common stock in connection with the settlement of a note payable in the amount of $74,104. The Company recorded a loss in the amount of $26,924 in connection with this transaction.

During the nine months ended September 30, 2018. there were no shares issued in connection with a legal settlement.